• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬菌体与人类免疫缺陷病毒1型:从展示到相互作用

Phages and HIV-1: from display to interplay.

作者信息

Delhalle Sylvie, Schmit Jean-Claude, Chevigné Andy

机构信息

Laboratory of Retrovirology, CRP-Sante, 84, Val Fleuri, L-1526 Luxembourg, Luxembourg.

Service National des Maladies Infectieuses, Centre Hospitalier Luxembourg, 4, rue E. Barblé, L-1210 Luxembourg, Luxembourg.

出版信息

Int J Mol Sci. 2012;13(4):4727-4794. doi: 10.3390/ijms13044727. Epub 2012 Apr 13.

DOI:10.3390/ijms13044727
PMID:22606007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3344243/
Abstract

The complex hide-and-seek game between HIV-1 and the host immune system has impaired the development of an efficient vaccine. In addition, the high variability of the virus impedes the long-term control of viral replication by small antiviral drugs. For more than 20 years, phage display technology has been intensively used in the field of HIV-1 to explore the epitope landscape recognized by monoclonal and polyclonal HIV-1-specific antibodies, thereby providing precious data about immunodominant and neutralizing epitopes. In parallel, biopanning experiments with various combinatorial or antibody fragment libraries were conducted on viral targets as well as host receptors to identify HIV-1 inhibitors. Besides these applications, phage display technology has been applied to characterize the enzymatic specificity of the HIV-1 protease. Phage particles also represent valuable alternative carriers displaying various HIV-1 antigens to the immune system and eliciting antiviral responses. This review presents and summarizes the different studies conducted with regard to the nature of phage libraries, target display mode and biopanning procedures.

摘要

人类免疫缺陷病毒1型(HIV-1)与宿主免疫系统之间复杂的捉迷藏游戏阻碍了高效疫苗的研发。此外,该病毒的高变异性妨碍了小分子抗病毒药物对病毒复制的长期控制。20多年来,噬菌体展示技术一直在HIV-1领域得到广泛应用,以探索单克隆和多克隆HIV-1特异性抗体所识别的表位图谱,从而提供有关免疫显性表位和中和表位的宝贵数据。与此同时,针对病毒靶点以及宿主受体开展了各种组合或抗体片段文库的淘选实验,以鉴定HIV-1抑制剂。除了这些应用,噬菌体展示技术还被用于表征HIV-1蛋白酶的酶促特异性。噬菌体颗粒也是向免疫系统展示各种HIV-1抗原并引发抗病毒反应的有价值的替代载体。本综述介绍并总结了有关噬菌体文库性质、靶点展示模式和淘选程序的不同研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49aa/3344243/a85d34faf5a6/ijms-13-04727f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49aa/3344243/2d4459e50d3f/ijms-13-04727f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49aa/3344243/ca339b8a9757/ijms-13-04727f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49aa/3344243/4e179bd1e906/ijms-13-04727f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49aa/3344243/508273a022b9/ijms-13-04727f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49aa/3344243/a85d34faf5a6/ijms-13-04727f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49aa/3344243/2d4459e50d3f/ijms-13-04727f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49aa/3344243/ca339b8a9757/ijms-13-04727f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49aa/3344243/4e179bd1e906/ijms-13-04727f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49aa/3344243/508273a022b9/ijms-13-04727f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49aa/3344243/a85d34faf5a6/ijms-13-04727f5.jpg

相似文献

1
Phages and HIV-1: from display to interplay.噬菌体与人类免疫缺陷病毒1型:从展示到相互作用
Int J Mol Sci. 2012;13(4):4727-4794. doi: 10.3390/ijms13044727. Epub 2012 Apr 13.
2
Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries.能结合病毒糖蛋白中不连续表位的抗人免疫缺陷病毒1型人单克隆抗体可从重组噬菌体肽展示文库中鉴定模拟表位。
AIDS Res Hum Retroviruses. 1997 Dec 10;13(18):1549-59. doi: 10.1089/aid.1997.13.1549.
3
Mimotopes selected by biopanning with high-titer HIV-neutralizing antibodies in plasma from Chinese slow progressors.通过从中国艾滋病病毒缓慢进展者血浆中高滴度中和抗体的生物淘选,选择模拟表位。
Braz J Infect Dis. 2012 Nov-Dec;16(6):510-6. doi: 10.1016/j.bjid.2012.07.003. Epub 2012 Nov 9.
4
Selection and immune recognition of HIV-1 MPER mimotopes.HIV-1 MPER 模拟表位的选择和免疫识别。
Virology. 2020 Nov;550:99-108. doi: 10.1016/j.virol.2020.06.016. Epub 2020 Sep 19.
5
Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library.通过基于包膜蛋白的噬菌体展示文库鉴定 gp41 膜近端外部区中 HIV 中和抗体的新表位。
Eur J Immunol. 2013 Feb;43(2):499-509. doi: 10.1002/eji.201242974. Epub 2012 Dec 27.
6
Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.在CCR5限制性而非CXCR4利用型的原发性人类免疫缺陷病毒1型毒株的天然包膜糖蛋白寡聚体中,一个保守的、CD4诱导性V3环中和表位的隐秘性质。
J Virol. 2005 Jun;79(11):6957-68. doi: 10.1128/JVI.79.11.6957-6968.2005.
7
Phage-displayed mimotopes recognizing a biologically active anti-HIV-1 gp120 murine monoclonal antibody.识别具有生物活性的抗HIV-1 gp120鼠单克隆抗体的噬菌体展示模拟表位。
J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):147-53. doi: 10.1097/00126334-200210010-00004.
8
Selection of peptide mimics of HIV-1 epitope recognized by neutralizing antibody VRC01.选择可被中和抗体VRC01识别的HIV-1表位的肽模拟物。
PLoS One. 2015 Mar 18;10(3):e0120847. doi: 10.1371/journal.pone.0120847. eCollection 2015.
9
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.筛选出的与gp120-CD4-CCR5复合物结合的具有广泛交叉反应性的HIV-1中和人单克隆Fab。
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6913-8. doi: 10.1073/pnas.102562599. Epub 2002 May 7.
10
Functional characterization of two scFv-Fc antibodies from an HIV controller selected on soluble HIV-1 Env complexes: a neutralizing V3- and a trimer-specific gp41 antibody.从在可溶性HIV-1包膜复合物上筛选出的一名HIV控制者体内获得的两种单链抗体片段-免疫球蛋白Fc段融合抗体的功能特性:一种中和性V3抗体和一种三聚体特异性gp41抗体。
PLoS One. 2014 May 14;9(5):e97478. doi: 10.1371/journal.pone.0097478. eCollection 2014.

引用本文的文献

1
Discovery of Antivirals Using Phage Display.利用噬菌体展示技术发现抗病毒药物。
Viruses. 2021 Jun 10;13(6):1120. doi: 10.3390/v13061120.
2
The Application of Porphyrins and Their Analogues for Inactivation of Viruses.卟啉及其类似物在病毒失活中的应用。
Molecules. 2020 Sep 23;25(19):4368. doi: 10.3390/molecules25194368.
3
Peptide-Based Vaccination for Antibody Responses Against HIV.基于肽的针对HIV抗体反应的疫苗接种

本文引用的文献

1
The Antibody Response against HIV-1.HIV-1 的抗体反应。
Cold Spring Harb Perspect Med. 2012 Jan;2(1):a007039. doi: 10.1101/cshperspect.a007039.
2
Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens.从人脐带血中鉴定种系抗体库并筛选针对病毒包膜糖蛋白的单克隆抗体:对免疫逃逸机制和疫苗免疫原设计的启示。
Biochem Biophys Res Commun. 2012 Jan 27;417(4):1164-9. doi: 10.1016/j.bbrc.2011.12.089. Epub 2011 Dec 27.
3
Nanobodies®: new ammunition to battle viruses.
Vaccines (Basel). 2019 Sep 2;7(3):105. doi: 10.3390/vaccines7030105.
4
Comprehensive Profiling of HIV Antibody Evolution.全面剖析 HIV 抗体进化
Cell Rep. 2019 Apr 30;27(5):1422-1433.e4. doi: 10.1016/j.celrep.2019.03.097.
5
Reverse Immunology Approach to Define a New HIV-gp41-Neutralizing Epitope.反向免疫学方法定义新型 HIV-gp41 中和表位。
J Immunol Res. 2019 Mar 24;2019:9804584. doi: 10.1155/2019/9804584. eCollection 2019.
6
The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses.迈向基于抗体的 HIV-1 Env 疫苗的艰难之路:来自其他病毒的教训。
Viruses. 2018 Apr 15;10(4):197. doi: 10.3390/v10040197.
7
Profiling the Extended Cleavage Specificity of the House Dust Mite Protease Allergens Der p 1, Der p 3 and Der p 6 for the Prediction of New Cell Surface Protein Substrates.分析屋尘螨蛋白酶过敏原Der p 1、Der p 3和Der p 6的扩展切割特异性以预测新的细胞表面蛋白底物
Int J Mol Sci. 2017 Jun 27;18(7):1373. doi: 10.3390/ijms18071373.
8
Selection of peptide mimics of HIV-1 epitope recognized by neutralizing antibody VRC01.选择可被中和抗体VRC01识别的HIV-1表位的肽模拟物。
PLoS One. 2015 Mar 18;10(3):e0120847. doi: 10.1371/journal.pone.0120847. eCollection 2015.
9
Bacteriophages and medical oncology: targeted gene therapy of cancer.噬菌体与医学肿瘤学:癌症的靶向基因治疗
Med Oncol. 2014 Aug;31(8):110. doi: 10.1007/s12032-014-0110-9. Epub 2014 Jul 11.
纳米抗体®:对抗病毒的新武器。
Antiviral Res. 2011 Dec;92(3):389-407. doi: 10.1016/j.antiviral.2011.09.002. Epub 2011 Sep 10.
4
Synthetic Fab fragments that bind the HIV-1 gp41 heptad repeat regions.与 HIV-1 gp41 七肽重复区结合的合成 Fab 片段。
Biochem Biophys Res Commun. 2011 Oct 7;413(4):611-5. doi: 10.1016/j.bbrc.2011.09.012. Epub 2011 Sep 6.
5
Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies.从一位具有 2F5 样抗体的患者中鉴定出的交叉反应性 HIV-1 中和人源单克隆抗体。
J Virol. 2011 Nov;85(21):11401-8. doi: 10.1128/JVI.05312-11. Epub 2011 Aug 31.
6
Engineering and screening the N-terminus of chemokines for drug discovery.针对药物发现工程和筛选趋化因子的 N 端。
Biochem Pharmacol. 2011 Nov 15;82(10):1438-56. doi: 10.1016/j.bcp.2011.07.091. Epub 2011 Jul 30.
7
Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins.与HIV-1包膜糖蛋白结合的交叉反应性人IgM衍生单克隆抗体。
Viruses. 2010 Feb;2(2):547-565. doi: 10.3390/v2020547.
8
Selection of a CXCR4 antagonist from a human heavy chain CDR3-derived phage library.从人源重链 CDR3 衍生噬菌体文库中筛选 CXCR4 拮抗剂。
FEBS J. 2011 Aug;278(16):2867-78. doi: 10.1111/j.1742-4658.2011.08208.x. Epub 2011 Jun 27.
9
Variable epitope libraries: new vaccine immunogens capable of inducing broad human immunodeficiency virus type 1-neutralizing antibody response.可变表位文库:能够诱导广泛的人类免疫缺陷病毒 1 中和抗体反应的新型疫苗免疫原。
Vaccine. 2011 Jul 18;29(32):5313-21. doi: 10.1016/j.vaccine.2011.05.007. Epub 2011 May 19.
10
A motif unique to the human DEAD-box protein DDX3 is important for nucleic acid binding, ATP hydrolysis, RNA/DNA unwinding and HIV-1 replication.一个独特的基序,对人类 DEAD-box 蛋白 DDX3 对核酸结合、ATP 水解、RNA/DNA 解旋和 HIV-1 复制是重要的。
PLoS One. 2011 May 12;6(5):e19810. doi: 10.1371/journal.pone.0019810.